Dr. Brian William Morrison, MD

Dr. Morrison practices at UMiami Medicine - Dermatology in Miami, Florida.

Dr. Morrison's NPI, 1134412083, was assigned on May 25, 2011. Dr. Morrison graduated from New York University School of Medicine in 2010. Dr. Morrison holds Florida license ME118877.

Dr. Morrison's primary practice is UMiami Medicine - Dermatology, at 1444 NW 9th Ave, Miami, FL 33136 in Miami-Dade County. The practice phone is (305) 243-7688.

Dr. Morrison's primary practice is UMiami Medicine - Dermatology in Miami, Florida. Dr. Morrison is also affiliated with Sylvester Comprehensive Cancer Center. The medical group on file is University of Miami Health System. Dmand AI also links Dr. Morrison to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Morrison practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Morrison's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Morrison is board certified in dermatology by the American Board of Dermatology. Dr. Morrison is licensed in Florida.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, contact dermatitis, hives, itchy rashes, joint cyst and minor injury to a limb among the conditions Dr. Morrison treats.

CMS data shows 870 Medicare services from Dr. Morrison across 12 procedure codes in 2024, for 232 Medicare patients. Medicare paid $49,663 for them. Every service was in an office.

CMS counts 232 Medicare patients who saw Dr. Morrison in 2024. The largest group is 65 to 74, with 119 patients. 75% of them have high cholesterol, and 65% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.03, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Morrison's median patient age at 56, with 51% women.

In 2024, Dr. Morrison wrote 715 Medicare Part D claims for 182 patients. 83% of them were for generic drugs. CMS names the drug for 575 of them, across 16 drugs with 11 or more claims each, at $291,192 in total drug cost. In 2023, CMS named 492 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Morrison for performance year 2024, reported as part of a group. Dr. Morrison accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 162 procedures of removal of skin lesions by Dr. Morrison, more than 78% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 29 papers to Dr. Morrison, published from 2014 to 2025. 2023 was the busiest year, with 6. The most frequent topics are Nail Diseases, Nails and Skin Neoplasms. Dr. Morrison has published most often in Skin Appendage Disord. Dr. Morrison's most frequent co-authors are Antonella Tosti, MD, Divya Joseph Aickara, MD and Anna Haydee Chacon, MD.

CMS Open Payments shows 68 general payments to Dr. Morrison from 21 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 61% of the total. UCB, Inc. paid the most, $3,228.

Dr. Morrison graduated from New York University School of Medicine in 2010.

Dr. Morrison is in network with 10 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 6. Check the plan with the practice before a visit.